Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuCNS-SC in Geographic Atrophy of AMD
NCT02467634Phase 2Terminated
- Sponsor
- StemCells, Inc.
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HuCNS-SC in geographic atrophy (GA), sponsored by StemCells, Inc.. Started Jun 2015; status: terminated.
02
Drugs
HuCNS-SC
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT02467634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467634.